Abstract
Purpose
The impact of body mass index (BMI) on patients with upper urinary tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU) is controversial. Increasing evidence suggests an age-dependent relationship between obesity and outcomes for some solid organ tumors. Herein, we aimed to assess the prognostic value of preoperative BMI in UTUC patients treated with RNU in Taiwan.
Methods
This was a retrospective single-center study of 468 UTUC patients undergoing RNU during January 2010–December 2017, with preoperative BMI classification and subgroup analysis based on ages of < or ≥ 70 years. All UTUC patients underwent RNU and bladder cuff excision. Overall survival (OS), cancer-specific survival, and disease-free survival (DFS) were analyzed. Fisher’s exact test, Mann–Whitney U test, Kaplan–Meier method, and Cox regression model were used for data analysis.
Results
The median follow-up duration was 36 months. Patients with higher versus lower BMI (cutoff: 25 kg/m2) showed no differences in OS; older patients had poor OS (hazard ratio [HR] 1.74; 95% confidence interval [CI] 1.24–2.40; p < 0.001). Older age was an independent predictor of poor OS in multivariate Cox regression analysis (p = 0.001). Younger patients with higher BMI (p = 0.02) had better DFS than older patients with no BMI-related survival differences. Higher BMI was an independent predictor of favorable DFS in younger patients in multivariate Cox regression analysis (HR, 0.53; 95% CI 0.28–0.99; p = 0.043).
Conclusion
Younger UTUC patients with higher BMI were independently associated with a favorable DFS.
Similar content being viewed by others
Availability of data and material
The datasets analyzed during the current study are available from the corresponding author upon reasonable request.
Code availability
Not applicable.
References
Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H et al (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356:j477. https://doi.org/10.1136/bmj.j477
Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4:486–501. https://doi.org/10.1158/1940-6207.CAPR-10-0229
Soualhi A, Rammant E, George G, Russell B, Enting D, Nair R et al (2021) The incidence and prevalence of upper tract urothelial carcinoma: a systematic review. BMC Urol 21:110. https://doi.org/10.1186/s12894-021-00876-7
Ehdaie B, Chromecki TF, Lee RK, Lotan Y, Margulis V, Karakiewicz PI et al (2011) Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol 186:66–72. https://doi.org/10.1016/j.juro.2011.03.031
Liu JY, Li YH, Liu ZW, Zhang ZL, Ye YL, Yao K et al (2014) Influence of body mass index on oncological outcomes in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Int J Urol 21:136–142. https://doi.org/10.1111/iju.12208
Dabi Y, El Mrini M, Duquesnes I, Delongchamps NB, Sibony M, Zerbib M, Xylinas E (2018) Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 36:65–71. https://doi.org/10.1007/s00345-017-2095-4
Inamoto T, Sassa N, Hattori R, Ibuki N, Komura K, Minami K et al (2019) Influence of the body mass index and its effect on tumor characteristics and survival among a population with access to surgical management of upper tract urothelial carcinoma. Curr Urol 12:201–209. https://doi.org/10.1159/000499305
Kang HW, Do Jung H, Ha YS, Kim TH, Kwon TG, Byun SS et al (2015) Preoperative underweight patients with upper tract urothelial carcinoma survive less after radical nephroureterectomy. J Korean Med Sci 30:1483–1489. https://doi.org/10.3346/jkms.2015.30.10.1483
Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S et al (2014) Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control 25:1407–1418. https://doi.org/10.1007/s10552-014-0435-x
Amptoulach S, Gross G, Kalaitzakis E (2015) Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res 199:378–385. https://doi.org/10.1016/j.jss.2015.05.059
Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 68:741–746. https://doi.org/10.1016/j.urology.2006.05.024
Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G et al (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105:1862–1870. https://doi.org/10.1093/jnci/djt310
Tsang NM, Pai PC, Chuang CC, Chuang WC, Tseng CK, Chang KP et al (2016) Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 5:665–675. https://doi.org/10.1002/cam4.634
Wang S, Ren J (2018) Obesity paradox in aging: from prevalence to pathophysiology. Prog Cardiovasc Dis 61:182–189. https://doi.org/10.1016/j.pcad.2018.07.011
Wang Z (2015) Age-dependent decline of association between obesity and mortality: a systematic review and meta-analysis. Obes Res Clin Pract 9:1–11. https://doi.org/10.1016/j.orcp.2014.01.006
Byun SS, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG et al (2018) Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: a large multicenter retrospective analysis. J Surg Oncol 118:199–205. https://doi.org/10.1002/jso.25104
Genkinger JM, Kitahara CM, Bernstein L, de Gonzalez AB, Brotzman M, Elena JW et al (2015) Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol 26:2257–2266. https://doi.org/10.1093/annonc/mdv355
Yang MH, Chen KK, Yen CC, Wang WS, Chang YH, Huang WJ et al (2002) Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59:681–687. https://doi.org/10.1016/s0090-4295(02)01529-7
Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105:1672–1677. https://doi.org/10.1111/j.1464-410X.2009.09072.x
Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C et al (2011) Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol 29:473–480. https://doi.org/10.1007/s00345-011-0677-0
Perez-Montiel D, Suster S (2008) Upper urinary tract carcinomas: histological types and unusual morphological variants. Diagn Histopathol 14:48–54. https://doi.org/10.1016/j.mpdhp.2007.11.006
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Ishioka J, Masuda H, Kijima T, Tatokoro M, Yoshida S, Yokoyama M et al (2014) Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res 34:5683–5688
Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH (2015) Can body mass index predict survival outcomes in patients treated with radical nephroureterectomy for upper-tract urothelial carcinoma? Int Urol Nephrol 47:1311–1320. https://doi.org/10.1007/s11255-015-1039-4
Hosain GM, Khan MM, Amiel GE, Lerner SP, Latini DM, Chen GJ (2012) Racial/ethnic differences in upper-tract urothelial cancer. Ethn Dis 22:295–301
Singla N, Fang D, Su X, Bao Z, Cao Z, Jafri SM et al (2017) A multi-institutional comparison of clinicopathological characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States. J Urol 197:1208–1213. https://doi.org/10.1016/j.juro.2016.11.094
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M et al (2011) Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 108:E304–E309. https://doi.org/10.1111/j.1464-410X.2011.10188.x
Lan N, Lu Y, Zhang Y, Pu S, Xi H, Nie X, Liu J, Yuan W (2020) FTO—a common genetic basis for obesity and cancer. Front Genet 11:559138. https://doi.org/10.3389/fgene.2020.559138
Wen L, Pan X, Yu Y, Yang B (2020) Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity. BMC Urol 20:39. https://doi.org/10.1186/s12894-020-00612-7
Sasaki Y, Sasaki T, Kawai T, Morikawa T, Matsusaka K, Kunita A et al (2014) HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients. Int J Clin Exp Pathol 7:699–708
Langner C, Gross C, Rehak P, Ratschek M, Ruschoff J, Zigeuner R (2005) HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique. Urology 65:176–180. https://doi.org/10.1016/j.urology.2004.08.025
Tsai YS, Tzai TS, Chow NH, Wu CL (2005) Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract. Urology 66:1197–1202. https://doi.org/10.1016/j.urology.2005.06.117
Ray A (2017) Tumor-linked HER2 expression: association with obesity and lipid-related microenvironment. Horm Mol Biol Clin Investig. https://doi.org/10.1515/hmbci-2017-0020
Melton LJ 3rd (1985) Selection bias in the referral of patients and the natural history of surgical conditions. Mayo Clin Proc 60:880–885. https://doi.org/10.1016/s0025-6196(12)64794-6
Acknowledgements
The authors would like to thank Professor Kung-Hao Liang from the Department of Medical Research at Taipei Veterans General Hospital for providing generous support as a statistical consultant.
Funding
This research was partially funded by Taipei Veterans General Hospital, Taiwan (V109C-176, V109EP-014, V110C-164, 110EP-009, V111C-196, 111EP-007) and the National Science and Technology Council, Taiwan (MOST 111-2221-E-075-003).
Author information
Authors and Affiliations
Contributions
J-CC: data analysis, manuscript writing. T-HH: data collection. T-CW: data collection. I-SH: Data collection. Y-HF: data collection. C-CL: data collection. T-PL: data collection. H-JC: data collection. S-HL: data collection. J-YK: data collection. HHHW: data collection. Y-HC: data collection. ATLL: data collection. WJH: data collection. EY-HH: project development, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board/Ethics (IRB) Committee of Taipei Veterans General Hospital (IRB number: 2020-12-007BC).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, JC., Huang, TH., Wei, TC. et al. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. World J Urol 41, 3575–3583 (2023). https://doi.org/10.1007/s00345-023-04685-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-023-04685-5